Key result
Lower adiponectin plays a major role in obesity-related insulin resistance and atherosclerosis.
Why the study?
Adiponectin plays a major role in obesity-related insulin resistance and atherosclerosis, but its implications in the pathophysiology and treatment of insulin resistance and NAFLD require summarization.
Adiponectin is a key adipocytokine whose decreased levels are implicated in obesity-related insulin resistance and non-alcoholic fatty liver disease.
Answers are grounded in this paper and cite their sources.
Adiponectin may inform metabolic risk stratification in obesity; leaves open its diagnostic or therapeutic utility pending trials.
Obesity is a major risk factor for the development of the metabolic syndrome, a cluster of diseases including insulin resistance, type 2 diabetes, dyslipidemia, hypertension, microalbuminuria, atherosclerosis, and non-alcoholic steatohepatitis. On the other hand, it is now generally accepted that adipose tissue acts as an endocrine organ producing a number of substances with an important role in the regulation of food intake, energy expenditure and a series of metabolic processes. Adiponectin is a recently discovered hormone produced exclusively by adipocytes. In fact, adiponectin is considered currently as a major factor in obesity-related insulin resistance and atherosclerosis. This new hormone differs from other adipocytokines in that its production and concentrations are actually decreased in insulin resistant subjects. The aim of this review is to summarize the current knowledge about the chemistry and physiology of adiponectin and to discuss its implications in the pathophysiology and potential treatment of insulin resistance and non-alcoholic fatty liver disease.
No takes yet. Share an insight, caveat, or question.
Méndez‐Sánchez et al. (2006) conducted a review in Non-alcoholic fatty liver disease and insulin resistance. Adiponectin was evaluated. Adiponectin is an adipocyte-derived hormone whose concentrations are decreased in insulin-resistant subjects, playing a major role in obesity-related insulin resistance and atherosclerosis.
Synapse has enriched 10 related papers. Consider them for comparative context: